On Oct. 9, 2025, Celltrion announced announced that the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), biosimilar…
On Aug. 21, 2025, the Institute for Health Metrics and Evaluation (IHME) announced a recent study aimed to…
On Jul. 16, 2024, researchers at the National Institutes of Health (NIH) reported they have found that taking…
On Apr. 10, 2024, researchers at the National Institutes of Health (NIH) applied artificial intelligence (AI) to a…
On Apr. 3, 2023, a study from the National Eye Institute (NEI) identified rare genetic variants that could…
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…
On Mar. 17, 2020, researchers at the National Eye Institute (NEI) reported finding a protein that normally deposits…
On Dec. 16, 2019, researchers at the National Eye Institute launched a clinical trial to test the safety…
On Sept. 11, 2019, scientists at Sanford Burnham Prebys announced they had identified the long-sought structure of an…
On Jun. 7, 2018, the Wold Foundation of Wyoming announced a gift of $2.5 million to help in…
On Dec. 18, 2014, the University of Nebraska Medical Center announced it had received a $1.3 million gift…
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
On Oct. 29, 2010, The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research…
On Jun. 30, 2006, Genentech drug Lucentisﾙ (ranibizumab injection) was approved by the FDA for the treatment of…
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
In 1997, the University of Iowa established the Center for Macular Degeneration. The Center was later renamed the…
In 1993, Massachusetts Eye and Ear researchers discovered the Vascular endothelial growth factor (VEGF) molecule, implicated in diabetic…